Company news
Cumberland Pharmaceuticals Inc. news in 2021
Cumberland Pharmaceuticals Inc.'s news releases, calls and decks from 2021, newest first.
Caldolor® Now FDA Approved For Pre-Operative Administration
November 28, 2021
Cumberland Pharmaceuticals Reports Third Quarter 2021 Financial Results & Company Update
November 8, 2021
Cumberland Pharmaceuticals Launches RediTrex® Product Line For Active Rheumatoid, Juvenile Idiopathic And Severe Psoriatic Arthritis
September 28, 2021
Cumberland Pharmaceuticals Reports Second Quarter 2021 Financial Results & Company Update
August 9, 2021
Cumberland Pharmaceuticals To Announce Second Quarter 2021 Financial Results
August 2, 2021
Cumberland Pharmaceuticals Reports 2.5M Patient Doses Delivered, No Product Recalls, No FDA Issues in 2020
July 25, 2021
Cumberland Pharmaceuticals Names John Hamm New Chief Financial Officer
May 18, 2021
Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update
May 10, 2021
Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020
March 8, 2021
Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2020 Financial Results
March 1, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (2021)
Investor deck · 23 slides · 2021